On Steroids
2187
1383, 1367 (i-Pr, Me). 1H NMR: 0.658 s, 3 H (3 × H-18); 0.826 s, 3 H (3 × H-19); 0.861 d, 3 H
an d 0.864 d, 3 H, J = 6.7 (3 × H-26 an d 3 × H-27); 0.894 d, 3 H, J = 6.7 (3 × H-21); 3.52 m ,
1 H, W 1/2 = 24.3 (H-3α). EI MS, m/z: 402 (M+), 384 (402 – H2O), 369 (384 – Me). For
C
28H50O (402.7) calculated: 83.51% C, 12.51% H; foun d: 82.34% C, 12.68% H.
(20R)-7a-Hom o-5α-ch olestan -3β-yl Toluen esulfon ate (18)
A solution of alcoh ol 17 (90 m g, 0.22 m m ol) in pyridin e (1 m l) was treated with 4-toluen e-
sulfon yl ch loride (90 m g, 0.52 m m ol) an d th en allowed to stan d at room tem perature over-
n igh t. Th e reaction m ixture was decom posed with ice an d water, th e product was taken up
in to eth er an d th e eth ereal solution was worked up as usual to afford 118 m g (0.21 m m ol;
96%) of tosylate 18: m .p. 88–90 °C, [α]D +22 (c 0.318). IR: 3068, 3032 (=CH); 1370, 1179,
558, 557 (SO2); 1600, 1496, 1306, 1290, 2111, 1189, 1119, 1100, 1021, 832, 815, 706, 669,
458 (arom atic); 1039 (Me). 1H NMR: 0.633 s, 3 H (3 × H-18); 0.790 s, 3 H (3 × H-19);
0.855 d, 3 H an d 0.859 d, 3 H, J = 6.6 (3 × H-26 an d 3 × H-27); 0.880 d, 3 H, J = 6.4 (3 ×
H-21); 2.44 s, 3 H (CH3 (Tos)); 4.35 m , 1 H, W1/2 = 25.1 (H-3α); 7.32 m , 2 H an d 7.79 m ,
2 H (C6H4 (Tos)). EI MS, m/z: 556 (M+), 384 (M+ – TosOH), 369 (384 – Me). For C35H54O4S
(556.9) calculated: 75.49% C, 10.14% H, 5.76% S; foun d: 75.60% C, 9.94% H, 5.14% S.
(20R)-7a-Hom o-5α-ch olest-2-en e (19) an d (20R)-7a-Hom o-5α-ch olest-3-en e (20)
Tosylate 18 (110 m g, 0.20 m m ol) was h eated in sym -collidin e (5 m l) un der n itrogen atm o-
sph ere for 2 h . Sym -collidin e was th en distilled off un der reduced pressure, th e residue
treated with water, an d th e product was taken up in to eth er. Usual work-up an d evaporation
left 85 m g of a product, con tain in g a m ixture of two isom eric olefin s 19 an d 20, wh ich were
in separable due to th eir practically iden tical polarity.
(20R)-7a-Hom o-5α-ch olestan -2α,3α-diol (21)
a) From (20R)-2α,3α-dihydroxy-7a-homo-5α-cholestan-7-one (12): A solution of keton e 12
(40 m g, 0.09 m m ol) was treated with h ydrazin e h ydrate (5 m l; 90%) an d th en h eated un der
reflux for 2 h (un til th e disappearan ce of th e startin g m aterial on TLC). Th e m ixture was
th en cooled to room tem perature, an d eth ylen e glycol (5 m l) an d potassium h ydroxide
(150 m g) were added. Th e reaction m ixture was h eated carefully to 195 °C (with out reflux in
order to rem ove h ydrazin e h ydrate) an d th en at reflux for 2 h (un til TLC m on itorin g
sh owed a com plete decom position of th e h ydrazon e). Th e reaction m ixture was poured in to
a saturated sodium ch loride solution (20 m l) an d th e product was isolated with dieth yl
eth er. Usual work-up an d evaporation gave a residue (37 m g), wh ich was purified by pre-
parative TLC on 4 plates in ligh t petroleum –eth er (1:1) to afford 30 m g (0.07 m m ol; 78%) of
diol 21. An alytical sam ple was crystallized from aceton e: m .p. 135–137 °C, [α]D +50.2
(c 0.215). IR: 3625, 3585, 3391, 1052, 1020 (OH); 1384, 1367 (i-Pr, Me). 1H NMR: 0.657 s,
3 H (3 × H-18); 0.844 s, 3 H (3 × H-19); 0.862 d, 6 H, J = 6.5 (3 × H-26 an d 3 × H-27);
0.898 d, 3 H, J = 6.6 (3 × H-21); 3.65 m , 1 H, W1/2 = 21.8 (H-2β); 3.89 m , 1 H, W1/2 = 7.3
(H-3β). FAB MS, m/z: 401 [α]D (M+ + H) – H2O], 383 (401 – H2O). For C28H50O2 (418.7) cal-
culated: 80.32% C, 12.04% H; foun d: 80.02% C, 12.06% H.
b) From a mixture of (20R)-7a-homo-5α-cholest-2-ene (19) and (20R)-7a-homo-5α-cholest-3-ene
(20): A solution of osm ium tetroxide (4 m g, 0.02 m m ol) in 2-m eth ylpropan -2-ol (0.04 m l)
was added to a solution of alken es 19 an d 20 (85 m g, 0.20 m m ol) in aceton e (4 m l).
Collect. Czech. Chem. Commun. (Vol. 68) (2003)